93265-81-7
93265-81-7 structure
- Name: Ropidoxuridine
- Chemical Name: 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one
- CAS Number: 93265-81-7
- Molecular Formula: C9H11IN2O4
- Molecular Weight: 338.09900
- Catalog: Research Areas Cancer
- Create Date: 2018-11-28 11:38:28
- Modify Date: 2024-01-09 14:41:18
-
Ropidoxuridine (IPdR) is a novel orally available, halogenated thymidine analog and is a potential radiosensitizer for use in human tumors.
| Name | 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one |
|---|---|
| Synonyms |
5-Iodo-2-pyrimidinone-2'-deoxyribose
Ropidoxuridine (INN/USAN) IPdR Ropidoxuridine UNII-3HX21A3SQF Ropidoxuridine [USAN:INN] 5-Iodo-2-pyrimidinone 2' deoxyribonucleoside |
| Description | Ropidoxuridine (IPdR) is a novel orally available, halogenated thymidine analog and is a potential radiosensitizer for use in human tumors. |
|---|---|
| Related Catalog | |
| In Vitro | Ropidoxuridine is an orally bioavailable pro-drug of IUdR (5-iodo-2'-deoxyuridine). Ropidoxuridine demonstrates strong synergy effects with Alisertib at clinically relevant concentrations[1]. |
| In Vivo | In an orthotopic tumor model, Ropidoxuridine (750 mg/kg/day) and Alisertib (30 mg/kg/day) demonstrate strong synergy effects[1]. |
| References |
| Density | 2.22g/cm3 |
|---|---|
| Boiling Point | 478.6ºC at 760mmHg |
| Molecular Formula | C9H11IN2O4 |
| Molecular Weight | 338.09900 |
| Flash Point | 243.3ºC |
| Exact Mass | 337.97600 |
| PSA | 84.58000 |
| Index of Refraction | 1.759 |
|
~45%
93265-81-7 |
| Literature: Efange, Simon M. N.; Alessi, Elaine M.; Shih, H. C.; Cheng, Yung-Chi; Bardos, Thomas J. Journal of Medicinal Chemistry, 1985 , vol. 28, # 7 p. 904 - 910 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |